CLOs on the Move

Avita Medical

www.avitamedical.com

 
Avita Medical is a publicly listed regenerative medicine company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). The company`s lead product, ReCell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA- registered in Australia, and SFDA-cleared in China. ReCell is not available for sale in the United States; in the US ReCell is an investigational device limited by federal law to investigational use.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Brett Silton
Head of Corporate Compliance Profile
Donna Shiroma
General Counsel Profile

Similar Companies

Phillips Precision Inc.

Phillips Precision Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Tarheel Physicians Supply

Tarheel Physicians Supply is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Medical Systems

Global Medical Systems is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Z-Medica Corporation

Z-Medica, LLC is a privately-held medical device manufacturer based in Wallingford, CT that is focused on the development, sale, and marketing of innovative hemorrhage control products for healthcare providers, military personnel, the law enforcement community, first responders, and consumers around the globe. For over a decade, Z-Medica has helped save lives and improve medical outcomes with a growing portfolio of QuikClot hemostatic products that include Control, 4x4 Hemostatic Dressing, Radial, Interventional, Combat Gauze, Belt Trauma Kit, and Bleeding Control Bag. QuikClot products are manufactured in the United States.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.